REVIEW
Accepted on 03 Feb 2026
Neoadjuvant Chemotherapy-Induced Immune Remodeling in Ovarian Cancer: Implications for TIL Dynamics and Combination Immunotherapy
- 196 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Combination Immune Therapies for the Treatment or Prevention of Breast or Gynecological Cancers
Combination Immune Therapies for the Treatment or Prevention of Breast or Gynecological Cancers
803
Total downloads
6,130
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 06 Nov 2025
Enhanced anti-tumor efficacy of tumor-infiltrating lymphocytes by GITR agonist in ovarian cancer
doi 10.3389/fimmu.2025.1670841
- 2,277 views
ORIGINAL RESEARCH
Published on 29 May 2025
Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting
doi 10.3389/fonc.2025.1564888
- 2,084 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: